Researchers at Turku University and Åbo Akademi University, Finland, have identified that finger-like cellular extensions called filopodia contribute to building a barrier surrounding breast tumours.
The Hospital District of Southwest Finland has chosen the Turku Immunology Centre as its unit of excellence. The Centre, which was established at the end of 2021, was also selected to the Roadmap for Research Infrastructures of the University of Turku.
Although a majority of pregnant women believed that they were aware of the recommendations on food supplement use, the recommendations were not always adhered to in practice, shows a study conducted at the University of Turku, Finland. The comparison of four countries shows that the use of food supplements was most common in Finland and least common in Italy.
Registration to BioCity Symposium is open until 11 August 2022. BioCity Symposium is one of the most important meetings in Turku region for researchers working in the fields of bio- and molecular medicine. This year the event is arranged together with InFLAMES Flagship with title Solution is in Immunity.
The University of Turku, the University of Münster and the University Medical Center Utrecht are developing new solutions for online teaching based on visual material. During the EU-sponsored project, which will run until 2023, new digital tools coupled with innovative pedagogical scenarios will be tested in the teaching of pathology. At the University of Turku, there are researchers from the Faculty of Education and the Faculty of Medicine involved in the project.
This year BioCity Symposium is arranged on-site in Mauno Conference Centre, BioCity, together with InFLAMES Research Flagship 25–26 August 2022, with the title Solution is in Immunity. Registration is now open until 11 August 2022.
The coronavirus launched a pandemic, but also a wave of new research. In spring 2020, most virologists around the world started to study the new, unknown virus. The challenge was also taken up at the University of Turku and Turku University Hospital (Tyks). Eighteen months into the pandemic, the number of international medical publications related to the virus in PubMed is already around 170,000, which is a truly exceptional number.
A new Finnish study shows that 180 health care workers who had received two doses of the Pfizer and Biontech vaccine have very good antibody responses against the SARS-CoV-2 virus. The immune response was as strong against the alpha variant (formerly the UK variant) but was somewhat decreased against the beta variant (formerly the South Africa variant).
Although vaccination programmes against pertussis are very effective in Europe, new Finnish study shows that the disease is still very common among middle-aged adults in various European countries. At the same time, the results show that the disease is underdiagnosed as the annually reported figures are considerably lower than those discovered in the study.
A research group at the University of Turku has led the development of a new method to evaluate vaccine safety. The new method may significantly reduce the use of animal testing in the vaccine industry.